Author:
Peng Tzu-Rong,Wu Chao–Chuan,Chang Sou-Yi,Chen Yen-Chih,Wu Ta-Wei,Hsu Ching-Sheng
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference31 articles.
1. A. Vogel, A. Cervantes, I. Chau, B. Daniele, J.M. Llovet, T. Meyer, et al., Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up, Ann. Oncol. 29 (Suppl. 4) (2018) iv238–iv255.
2. Global Burden of Disease Liver Cancer Collaboration, T. Akinyemiju, S. Abera, M. Ahmed, N. Alam, M.A. Alemayohu, C. Allen, et al., The Burden of Primary Liver Cancer and Underlying Etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015, JAMA. Oncol. 3(12) (2017) 1683–1691.
3. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma;J. Hepatol.,2018
4. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers.,2021
5. Sequencing treatments in hepatocellular carcinoma: will value frameworks provide a solution?;Li;JCO. Oncol. Pract.,2021
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献